Gori S - Search Results

1

Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group.

Musacchio L, Palluzzi E, Di Napoli M, Lauria R, Ferrandina G, Angioli R, Bergamini A, Corrado G, Perniola G, Cassani C, Savarese A, Gori S, Greco F, De Angelis C, Zafarana E, Giannarelli D, Cinieri S, Mosconi AM, Raspagliesi F, Pignata S, Scambia G, Lorusso D. Musacchio L, et al. Among authors: gori s. Gynecol Oncol. 2024 Jan 25;184:24-30. doi: 10.1016/j.ygyno.2024.01.022. Online ahead of print. Gynecol Oncol. 2024. PMID: 38277918

2

Chemotherapy with cis-platin, doxorubicin, and cyclophosphamide (CAP) in patients with metastatic breast cancer.

Colozza M, Gori S, Mosconi AM, Belsanti V, Basurto C, Rossetti R, Di Costanzo F, Buzzi F, Bacchi M, Davis S, et al. Colozza M, et al. Among authors: gori s. Am J Clin Oncol. 1989 Apr;12(2):137-41. doi: 10.1097/00000421-198904000-00010. Am J Clin Oncol. 1989. PMID: 2705403

3

Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer. Long-term results.

Colozza M, Gori S, Mosconi AM, Anastasi P, de Angelis V, Giansanti M, Mercati U, Aristei C, Latini P, Tonato M. Colozza M, et al. Among authors: gori s. Am J Clin Oncol. 1996 Feb;19(1):10-7. doi: 10.1097/00000421-199602000-00003. Am J Clin Oncol. 1996. PMID: 8554028 Clinical Trial.

4

Salvage chemotherapy in metastatic breast cancer: an experience with the combination of mitoxantrone, 5-fluorouracil, and L-leucovorin.

Colozza M, Gori S, Mosconi AM, Anastasi P, Basurto C, Ludovini V, De Angelis V, Giansanti M, Tonato M. Colozza M, et al. Among authors: gori s. Breast Cancer Res Treat. 1996;38(3):277-82. doi: 10.1007/BF01806146. Breast Cancer Res Treat. 1996. PMID: 8739080 Clinical Trial.

5

Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.

Colozza M, Mosconi AM, Gori S, Belsanti V, Basurto C, De Angelis V, Giansanti M, Tonato M. Colozza M, et al. Among authors: gori s. Am J Clin Oncol. 1997 Oct;20(5):522-6. doi: 10.1097/00000421-199710000-00019. Am J Clin Oncol. 1997. PMID: 9345342 Clinical Trial.

6

Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients.

Gori S, Mosconi AM, Tabilio A, Falzetti F, Aristei C, Basurto C, Cherubini R, Latini P, Martelli MF, Tonato M, Colozza M. Gori S, et al. Tumori. 2001 May-Jun;87(3):138-41. doi: 10.1177/030089160108700306. Tumori. 2001. PMID: 11504367

7

Weekly paclitaxel in metastatic breast cancer patients: a phase II study.

Gori S, Mosconi AM, Basurtol C, Cherubinil R, De Angelis V, Tonato M, Colozza M. Gori S, et al. Tumori. 2002 Nov-Dec;88(6):470-3. doi: 10.1177/030089160208800607. Tumori. 2002. PMID: 12597140 Clinical Trial.

8

Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer.

Gori S, Colozza M, Mosconi AM, Franceschi E, Basurto C, Cherubini R, Sidoni A, Rulli A, Bisacci C, De Angelis V, Crinò L, Tonato M. Gori S, et al. Br J Cancer. 2004 Jan 12;90(1):36-40. doi: 10.1038/sj.bjc.6601485. Br J Cancer. 2004. PMID: 14710203 Free PMC article. Clinical Trial.

9

Safety of epirubicin adjuvant chemotherapy in a breast cancer patient with chronic renal failure undergoing hemodialytic treatment.

Gori S, Rulli A, Mosconi AM, Sidoni A, Colozza M, Crinò L. Gori S, et al. Tumori. 2006 Jul-Aug;92(4):364-5. doi: 10.1177/030089160609200421. Tumori. 2006. PMID: 17036534

10

Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial.

Nuzzo F, Morabito A, De Maio E, Di Rella F, Gravina A, Labonia V, Landi G, Pacilio C, Piccirillo MC, Rossi E, D'Aiuto G, Thomas R, Gori S, Colozza M, De Placido S, Lauria R, Signoriello G, Gallo C, Perrone F, de Matteis A. Nuzzo F, et al. Among authors: gori s. Crit Rev Oncol Hematol. 2008 May;66(2):171-80. doi: 10.1016/j.critrevonc.2007.10.006. Epub 2007 Dec 21. Crit Rev Oncol Hematol. 2008. PMID: 18160303 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

434 results

Search Page